Learn More
Selleck Chemical LLC Risankizumab-A2046-1MG

Supplier: Selleck Chemical LLC A20461MG
Risankizumab targets the p19 subunit of IL-23 Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn s disease
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.